Emory University researchers have launched a five-year clinical trial in northwest Georgia to test whether a commonly used medication can reduce levels of PFAS, the so-called forever chemicals, already in people's blood. The trial is open to adults in the Rome and Calhoun areas, where decades of stain-resistant chemical use by the region's carpet industry contributed to widespread contamination, the Atlanta Journal-Constitution reported in its coverage of the trial. The AJC described the medication as a cholesterol-lowering drug.
The trial is testing an idea, and it has no results yet. No treatment is currently proven to lower PFAS levels in the body.
